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a b s t r a c t
The interaction between proteins and cell receptors is related to tissue homeostasis such as
in salivary glands. In this respect, alterations in hormone levels caused by hyperglycaemic
conditions may interfere with this interaction, intensifying the damage caused by diabetes
mellitus. Hormone replacement therapy is an option to reverse this damage, but doubts still
exist regarding the efficacy of this procedure. The objective of this study was to evaluate the
effect of oestrogen replacement therapy combined with insulin treatment on the expression
of oestrogen (ER-alpha) and insulin receptors (INS-R) in the salivary glands of spontaneously
diabetic mice. Twenty-five mice were divided into five group of 5 animals each: group I (NOD
diabetic), group II (NOD diabetic treated with insulin), group III (NOD diabetic treated with
oestrogen), group IV (NOD diabetic treated with insulin and oestrogen), and group V (control
BALB/c mice). Group II received insulin, group III received oestrogen, and group IV received
insulin plus oestrogen administered daily for 20 days. Groups I and V received saline for the
same period of time to simulate treatment. Glucose and oestrogen levels were monitored
during the experimental period and salivary gland samples were collected at the end of the
experiment for fluorescence microscopy analysis of ER-alpha and INS-R. Animals receiving
oestrogen replacement therapy plus insulin showed regulation of the expression of oestro-
gen and insulin receptors. Oestrogen treatment alone contributed to the recovery of these
cell receptors. These results indicate that oestrogen replacement therapy alone, and
especially when combined with insulin, is important for the recovery of the interaction
between functional proteins and their receptors, thus contributing to the reestablishment of
tissues damaged by the hyperglycaemic condition.
# 2011 Elsevier Ltd. 
avai lab le at www . s c ien c edi r ect . co m
journal homepage: http://www.elsevier.com/locate/aob
Open access under the Elsevier OA license.1. Introduction
The number of individuals with diabetes mellitus has been
increasing worldwide. In Brazil, 5.2% of the adult population
has this disease and in the United States 72,507 of deaths are* Corresponding author at: Department of Morphology and Basic Patho
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Open access under the Elsevier OA license.related to this hyperglycaemic condition, with diabetes being
amongst the 10 leading causes of death in that country.1–4
These data are important since diabetes is an irreversible
disease and is associated with hormone alterations that result
in various complications in the patient, including involvement
of the salivary glands.5–13logy, Faculty of Medicine of Jundiaı´, FMJ, Rua Francisco Telles, 250,
095.
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hormones that regulate cell activity. These biological effects
are mediated by the interaction between hormones and
cellular receptors.14–19 In this respect, insulin is the main
hormone involved in the regulation of cell growth and its
action is mediated by receptors (INS-R).20–22 Understanding
the relationship between functional proteins and tissues and
the impaired interaction in hyperglycaemic conditions, some
studies have tried to reverse this damage by treatment with
hypoglycaemic agents. For example, various investigators
studied the effect of insulin on the salivary glands. The results
showed that, despite beneficial metabolic effects, doubts exist
regarding the true recovery of tissues in response to this type
of treatment.23–25 This reflects a complex mechanism of action
since hormones other than insulin may interfere with this
process, such as insulin-like growth factors and male and
female sex hormones depending on gender.15,17,18,26–32 An-
other hormone is oestrogen, which also plays a role in cell
function, glucose metabolism, and insulin secretion. In
addition, oestrogen has been associated with an increased
risk of diabetes. Diabetes alters these hormones, compromis-
ing their function and intensifying the damage caused by the
hyperglycaemic condition.33–36
Hormone replacement therapy then may reverse this
damage, but due to the presence of various complications
doubts still exist regarding the total efficacy of this procedure
in different cases, including hyperglycaemic conditions.37–40
Therefore, the objective of the present study was to evaluate
the effect of oestrogen replacement therapy and prolonged
insulin treatment on the expression of INS-R and ER-alpha in
the salivary glands of spontaneously diabetic mice, associat-
ing the therapeutic action of these treatments with the
recovery of glandular tissues.
2. Materials and methods
2.1. Animals and experimental conditions
Twenty-five 15-week-old female mice weighing on average
20 g, obtained from the Animal House of Universidade
Estadual de Campinas (CEMIB, certified by ICLAS), were
divided into five groups of 5 animals each: group I (NOD
diabetic), group II (NOD diabetic treated with insulin), group III
(NOD diabetic treated with oestrogen), group IV (NOD diabetic
treated with insulin and oestrogen), and group V (control
BALB/c mice). The animals were kept under standard condi-
tions of housing, feeding and treatment at the Sector of
Laboratory Animal Experimentation, Department of Morphol-
ogy and Basic Pathology, Faculty of Medicine of Jundiaı´, FMJ.
Group II received insulin 20 days after confirmation of the
hyperglycaemic condition (highly purified mixed NPH insulin,
Biobra´s, Minas Gerais, Brazil). Insulin was administered
subcutaneously at a daily dose of 0.20 ml/100 g (4–5 U) for a
period of 20 days similar as described by Anderson.24 Group III
received physiological doses of oestrogen in the form of daily
subcutaneous injections of 72 mg 17b-oestradiol/kg41 (Sigma
Chemical, St. Louis, MO, USA), also for a period of 20 days.
Group IV received oestrogen plus insulin using the same
protocol. Mice of groups I and V received daily subcutaneousinjections of saline (4–5 U) to simulate the experimental
conditions of the treated groups.42
Blood glucose levels (mg/dl) were monitored weekly in all
animals with the Accu-Chek Performa System (Roche, Nutley,
NJ, USA). Diabetes was defined as glucose levels higher than
300 mg/dl.43 Oestrogen levels were measured at the beginning
and at the end of treatment for confirmation of the
physiological hormone dose.44 For this purpose, a part of
the blood sample was centrifuged for the separation of serum.
Oestradiol levels were assayed using the oestradiol kit
(Diagnostic Products, Los Angeles, CA, USA) in a Labsystems
Multiskan Ascent plate reader (Model 354, Thermo Fisher
Scientific, Suwanee, Georgia, USA).
After treatment, the animals of all groups were anaesthe-
tized with ketamine/xylazine (1:1) at a dose of 0.1 ml/29 g body
weight and samples of the parotid and submandibular glands
were collected. The animals were then sacrificed with an
overdose of the anaesthetic according to the ethical guidelines
of the Brazilian College of Animal Experimentation (COBEA).
The salivary gland samples were analysed by fluorescence
microscopy for the observation of INS-R and ER-alpha.
2.2. Fluorescence microscopy
Frozen samples of the salivary glands were cut into 12-mm thick
sections and incubated in blocking solution for 1 h at room
temperature for the blockade of nonspecific protein–protein
binding sites. Next, the material was incubated for 1 h with the
primary rabbit polyclonal antibody against ER-alpha (Santa
Cruz Biotechnology, San Diego, CA, USA). The slides were then
washed in phosphate buffered saline and incubated with the
fluorescent conjugated secondary antibody (goat anti-rabbit,
Santa Cruz Biotechnology, San Diego, CA, USA). The sections
were mounted in 1,4-diazabicyclo[2.2.2]-octane (Sigma, St.
Louis, MO, USA). For the evaluation of insulin receptors, a
similar protocol was applied using a primary antibody against
INS-R (Santa Cruz Biotechnology, San Diego, CA, USA) diluted in
blocking solution. After incubation with the primary antibody,
the sections were washed in phosphate buffered saline and the
secondary fluorescein-conjugated antibody (goat anti-rabbit,
Santa Cruz Biotechnology, San Diego, CA, USA) diluted in
blocking solution was applied. The sections were then washed
in phosphate buffered saline and mounted in 1,4-diazabicy-
clo[2.2.2]-octane (Sigma, St. Louis, MO, USA).
The specimens were examined under a TNI-06T-PL fluores-
cence microscope at the Department of Morphology and Basic
Pathology, Faculty of Medicine of Jundiaı´. The images were
acquired using 10 and 40 objectives. Sections in which the
primary antibody was omitted served as negative controls. The
intensity of staining was scored as intense, moderate and mild
according to the intensity and distribution of immunoexpres-
sion of the cellular receptors in the tissue sections.12,45
3. Results
3.1. Glucose levels
The mean glucose levels of untreated diabetic animals (group
I) were 500 mg/dl. There was recovery of glucose levels in
Fig. 1 – Immunostaining of the parotid glands. (A) Group V, intense INS-R (arrow). (B) Group V, mild ER-alpha staining
(arrow). (C) Group IV intense INS-R expression (arrow). (D) Group IV, mild ER-alpha expression (arrow). (E) Group III,
moderate INS-R staining (arrow). (F) Group III, moderate ER-alpha staining (arrow). (G) Group II, mild INS-R expression close
to the salivary ducts (arrow). (H) Group II, intense ER-alpha expression close to the cell nuclei (arrow). (I) Group I mild INS-R
expression, maintaining the pattern of localization (arrow). (J) Group I, intense ER-alpha expression (arrow).
a r c h i v e s o f o r a l b i o l o g y 5 6 ( 2 0 1 1 ) 1 1 2 9 – 1 1 3 6 1131
a r c h i v e s o f o r a l b i o l o g y 5 6 ( 2 0 1 1 ) 1 1 2 9 – 1 1 3 61132animals treated with insulin alone or combined with oestrogen,
with mean levels of 190 mg/dl. These levels were similar to
those of control animals (170 mg/dl). There was also a decrease
of glucose levels in animals undergoing only oestrogen
replacement therapy, with mean levels of 280 mg/dl.
3.2. Oestrogen levels
Mean blood oestrogen levels of groups III and IV
(89.3  18.2 pg/ml) were similar to that of the control group
(group V) (93.8  12.4 pg/ml). Mean oestrogen levels were
21.3  7.2 pg/ml in animals of groups I and II.
3.3. Fluorescence microscopy
3.3.1. Parotid gland
Group V showed intense expression of INS-R, mainly close to
the acini and glandular ducts (Fig. 1A). Oestrogen receptor (ER-
alpha) expression was mild and was localized in the nucleus of
ductal cells (Fig. 1B and Table 1). In group IV, expression of INS-
R was also intense and was observed close to the glandular
ducts (Fig. 1C). The ER-alpha was mild and showed a
localization similar to that observed in group V (Fig. 1D and
Table 1). However, in animals treated with oestrogen (group
III), INS-R and ER-alpha were expressed moderately (Fig. 1E
and F and Table 1). In animals treated with insulin (group II),
INS-R was expressed mildly and was mainly localized around
the salivary ducts. In contrast, expression of oestrogen
receptors was intense and these receptors were immunolo-
calized in epithelial cells, mainly close to the nuclei (Fig. 1G
and H and Table 1). Diabetic animals of group I showed mild
and intense expression of insulin and oestrogen receptors,
respectively (Fig. 1I and J and Table 1).
3.3.2. Submandibular gland
Expression of INS-R was intense in group V and was localized
close to the acini and mainly in the glandular ducts (Fig. 2A). In
this group, expression of ER-alpha was mild and was localized
in the nucleus of ductal cells (Fig. 2B and Table 1). In group IV,
INS-R was expressed intensely close to the salivary ducts
(Fig. 2C). ER-alpha showed mild expression close to the
nucleus of ductal cells (Fig. 2D and Table 1). In group III,
expression of ER-alpha and INS-R was moderate and was
localized close the nuclei of epithelial cells and glandular
ducts, respectively (Fig. 2E and F and Table 1). In animalsTable 1 – Distribution of the INS-R and ER-alpha accord-
ing to the intensity of expression in the salivary glands.
Group Parotid gland Submandibular
gland
INS-R ER-alpha INS-R ER-alpha
V +++ + +++ +
IV +++ + +++ +
III ++ ++ ++ ++
II + +++ + +++
I + +++ + +++
+: mild; ++: moderate; +++: intense.treated with insulin (group II), there was intense expression of
ER-alpha close the nuclei of epithelial cells. INS-R expression
was mild and mainly occurred close to the ducts (Fig. 2G and H
and Table 1). In group I, expression of INS-R and ER-alpha was
very mild and intense, respectively, maintaining the pattern of
localization (Fig. 2I and J and Table 1).
4. Discussion
In the present study, untreated diabetic animals showed
elevated glucose levels, whereas these levels returned to
normal and were similar to that of the control group in
animals treated with insulin alone and in combination with
oestrogen. It should be pointed out that glucose levels were
also significantly reduced in the group receiving only oestro-
gen. The non-obese diabetic (NOD) mouse represents one of
the best models of insulin-dependent diabetes.46 Insulin is an
anabolic hormone produced by the pancreas but is also
secreted to different extents by other organs and is known to
be a mediator of physiological events in the salivary glands.
Insulin regulates blood glucose levels and maintains the
homeostasis of different tissues.28,32,47,48 According to Hu
et al.,49 under the action of insulin normal glucose levels are
close to 180 mg/dl, whereas an effective diabetic state is
characterized by mean levels of 300 mg/dl or higher.43 In
addition to insulin, oestrogen also affects glucose metabolism
and insulin resistance and might be associated with the
development of diabetes mellitus.50 Other studies support
these findings. A study investigating men and women found
that diabetes was more frequent amongst men, especially
when associated with coronary events.51 This fact is probably
due to hormonal protection in women. With respect to
oestrogen, an experimental study has shown that a reduction
of oestrogen levels causes alterations in the mechanism of
action of insulin.52 Moreover, replacement therapy with
natural estrogens reduced insulin resistance, contributing to
the control of glucose levels.53 Although promising, these
findings demonstrate the complexity of the action of these
hormones, especially in hyperglycaemic conditions. In an
experimental study on oestrogen replacement therapy,
Ceylan-Isik et al. found no positive effects on glycaemic
control.40
The present results confirm the diabetic condition of the
animals and demonstrate the efficacy of insulin treatment in
glycaemic control. In addition, oestrogen at physiological
doses was important for the regulation of glucose levels.
However, further studies are necessary to better understand
the mechanism underlying the action of oestrogen and other
possible beneficial effects of this hormone.
Analysis of the salivary glands showed alterations in the
expression of cellular receptors in both untreated diabetic
animals and diabetic animals submitted to either treatment
alone. In contrast, recovery of the expression of INS-R and ER-
alpha occurred in the group receiving oestrogen plus insulin,
similar to what was observed in healthy animals. Various
factors including hormones act on the homeostatic mecha-
nism in different tissues, such as the salivary glands. Different
conditions such as diabetes mellitus can cause alterations in
hormone levels. This agrees with studies showing that
Fig. 2 – Immunostaining of submandibular glands. (A) Group V, intense expression of INS-R (arrow). (B) Group V, mild
expression of ER-alpha (arrow). (C) Group IV, intense INS-R staining (arrow). (D) Group IV, mild expression of ER-alpha (arrow).
(E) Group III, moderate INS-R staining (arrow). (F) Group III, moderate ER-alpha staining (arrow). (G) Group II, mild expression of
INS-R close to the salivary ducts (arrow). (H) Group II, intense expression of ER-alpha close to the cell nuclei (arrow). (I) Group I,
mild expression of INS-R, maintaining the pattern of localization (arrow). (J) Group I: intense expression of ER-alpha (arrow).
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dysfunctions.54 Thus, hormone alterations may act in a
feedback loop, potentiating the damage caused by diabetes
mellitus. Considering that oestrogen at normal levels plays an
important role as an immunoregulator, Ishimaru et al. studied
the effects of oestrogen deficiency in an experimental model.17
The authors observed a higher apoptotic activity in salivary
glands and an increase of autoimmune lesions, lesions that
are common in type I diabetes mellitus. Current evidence also
indicates that, in addition to hormone alterations, increased
expression of oestrogen receptors localized close the nuclei of
epithelial cells is related to the development of adenomas in
the salivary glands.55 In this respect, Kumar et al. reported the
involvement of ER-alpha in the development of tumours in
glandular tissue.56 These results are important when relating
oestrogen to diabetes since glucose metabolism and hyper-
glycaemic conditions have also been suggested to play a role in
the development of cancer.57,58 Thus, experimental evidence
from animal models indicates that oestrogen alterations may
participate in the pathogenesis of salivary gland.59 On the
other hand, the oestrogen and their receptors may regulate
gene expression and influence crucial physiological events in
target tissues.60 According to Tsinti et al. oestrogen receptors
are expressed in normal salivary gland epithelium and
apparently mediate functional and immunological effects.59
Under these conditions, oestrogen receptors are weakly
expressed close to the nuclei of ductal cells.55
The structure of the salivary glands and pancreas is similar.
The oestrogen then, may also participate in the maintenance
of pancreas by prevention of the pancreatic beta-cell apopto-
sis. This fact may interrupt the loss of critical beta-cell mass
and directly increase the secretory activity of this organ.61–63
Thus, Nadal et al. also emphasized this key role of the
oestrogen and its receptors in glucose and fat metabolism and
in the production of insulin, especially when activated by the
action of 17b-oestradiol.64 However, these mechanisms are
complex and oestrogen may not exert a direct effect on cell
proliferation or insulin production by pancreatic cells as
demonstrated in another study.65
This finding suggests that in cases of an increase in insulin
production and in the activity of its receptors, other organs
may participate in these processes. In an experimental study,
Caldeira and Cagnon showed that diabetes reduces the
expression of insulin receptors, characterizing alterations in
the production of insulin and in the interaction of this
hormone with cellular receptors.12 In this respect, there is
evidence indicating a relationship between insulin production
and the salivary glands. Although the salivary glands are
typically exocrine, He et al. demonstrated endocrine secre-
tions related to these tissues.66 Sa´nchez Garcı´a et al. observed
that insulin levels found in saliva are similar to plasma levels
under normal conditions.67 The authors suggested that this
insulin might be a product of the salivary glands, but further
studies are necessary to clarify this process.
Hormones such as oestrogen may act synergistically on cell
stimulation and contribute to the mechanisms of action and
production of insulin, opening up new treatment possibilities
for diabetes.68 Similar to what was observed in the present
study in which diabetes caused alterations in the expression of
oestrogen and insulin receptors in the salivary glands, alteringtissue homeostasis and compromising the protective and
digestive function of these organs. However, oestrogen
replacement therapy combined with insulin treatment
resulted in the recovery of the expression of these cellular
receptors. It should be pointed out that even oestrogen
treatment alone was important for the process of recovery
and tissue stimulation when compared to the untreated
diabetic group. The results also showed that the parotid gland
was less affected than the submandibular gland, demonstrat-
ing a better adaptation of this gland to hyperglycaemic
conditions or a better response to the treatment used.
Nevertheless, the findings show that oestrogen replace-
ment therapy alone, and especially when combined with
insulin, played an important role in the recovery of the
interaction between functional proteins and their receptors,
thus contributing to blood glucose lowering and reestablish-
ment of tissues damaged by the hyperglycaemic condition.
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